Physician profile
John E Anderson
NPI 1578520359
$1,028.21
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $95.78 · 2021: $632 · 2022: $55.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $786.53 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $60.58 | 2019 | |
| Zimmer Biomet Holdings, INC. | $49.02 | 2019 | |
| Terumo Cardiovascular Systems Corporation | $26.58 | 2019 | |
| Bard Access Systems, INC. | $25.05 | 2019 | |
| Abbott Laboratories | $21.28 | 2019 | |
| Abiomed | $19.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.12 | 2021 | |
| Davol INC. | $13.15 | 2019 | |
| Depuy Synthes Sales INC. | $11.93 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.